ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.